BACKGROUND: Opioids can exert adverse effects on the body. Morphine, an opioid drug, reduces hormone levels and fertility, and causes sexual activity disorders. Tribulus terrestris (TT) is a traditional herbal medicine used to enhance sexual activities. This study investigates the possible role of TT on sex hormones and gonadotropins with the intent to show its usefulness in treating fertility disorders in opioid users. MATERIALS AND METHODS: In this experimental study, we randomly divided 48 rats into four groups: i. control, ii. TT-treated, iii. addicted and iv. TT-treated addicted. Watersoluble morphine was administrated orally for 21 days to induce addiction, after which the treated groups 2 and 4 received plant-mixed pelleted food (6.25%) orally for four weeks. At the end of the treatment period, the sex hormone and gonadotropin levels of all rats' sera were determined by radioimmunoassay and Elisa kits. The data obtained were statistically analyzed using the one-way analysis of variance, followed by post-hoc Tukey test. P<0.05 was considered significant. RESULTS: The addicted group had a significantly lower luteinizing hormone (LH) level than the control group (p<0.027). LH levels increased significantly in the TT-treated addicted group (p<0.031). The testosterone level in the treated addicted group was lower than the treated control group. The addicted group had a significantly low testosterone level (p<0.001). The estrogen level was significantly (p<0.002) lower in the addicted group than in the control group. In addition, there was a significant difference between the treated addicted group and the treated control group (p<0.048). The treated control group had a significant increase in its progesterone level (p<0.002). Overall, except for follicle-stimulating hormone (FSH), morphine reduced most of the gonadotropins and sexual hormones. Whereas TT caused a considerable increase (p<0.05) in the hormones in the treated addicted group, there was only a slight increase in the treated control group. CONCLUSION: Oral consumption of TT could markedly antagonize the reduction of sex hormones and gonadotropins (except for FSH) due to morphine addiction.
BACKGROUND: Opioids can exert adverse effects on the body. Morphine, an opioid drug, reduces hormone levels and fertility, and causes sexual activity disorders. Tribulus terrestris (TT) is a traditional herbal medicine used to enhance sexual activities. This study investigates the possible role of TT on sex hormones and gonadotropins with the intent to show its usefulness in treating fertility disorders in opioid users. MATERIALS AND METHODS: In this experimental study, we randomly divided 48 rats into four groups: i. control, ii. TT-treated, iii. addicted and iv. TT-treated addicted. Watersoluble morphine was administrated orally for 21 days to induce addiction, after which the treated groups 2 and 4 received plant-mixed pelleted food (6.25%) orally for four weeks. At the end of the treatment period, the sex hormone and gonadotropin levels of all rats' sera were determined by radioimmunoassay and Elisa kits. The data obtained were statistically analyzed using the one-way analysis of variance, followed by post-hoc Tukey test. P<0.05 was considered significant. RESULTS: The addicted group had a significantly lower luteinizing hormone (LH) level than the control group (p<0.027). LH levels increased significantly in the TT-treated addicted group (p<0.031). The testosterone level in the treated addicted group was lower than the treated control group. The addicted group had a significantly low testosterone level (p<0.001). The estrogen level was significantly (p<0.002) lower in the addicted group than in the control group. In addition, there was a significant difference between the treated addicted group and the treated control group (p<0.048). The treated control group had a significant increase in its progesterone level (p<0.002). Overall, except for follicle-stimulating hormone (FSH), morphine reduced most of the gonadotropins and sexual hormones. Whereas TT caused a considerable increase (p<0.05) in the hormones in the treated addicted group, there was only a slight increase in the treated control group. CONCLUSION: Oral consumption of TT could markedly antagonize the reduction of sex hormones and gonadotropins (except for FSH) due to morphine addiction.
Entities:
Keywords:
FSH; LH; Morphine; Sex Hormones; Tribulus terrestris
Recent years have witnessed a dramatic rise in
the use of opioid drugs despite the documentation
of their numerous adverse effects in the literature.
One of these side effects is the negative impact on
sex hormone levels, libido, potency, and menorrhea
(1-3). A study has shown that 96% of men
and 69% of women who receive opioid analgesic drugs for pain management have decreased libido
or impotency (4). Also, it has been found that spinal
opiate analgesics reduce libido and cause difficulty
in achieving or maintaining an erection in
men (5).One of the most commonly used opioid drugs
is morphine. In a prospective, uncontrolled,
non-randomized study, a group of men with an
average pain duration of 11 years used intrathecal
morphine for 12 weeks. Most of the patients
reported poor libido and erectile difficulty toward
the end of the 12-week period; in addition,
testosterone and follicle-stimulating hormone
(FSH) levels significantly reduced. The intrathecal
opioid caused a reduction in hormone levels
(6).Tribulus terrestris (TT), commonly known as
caltrop or devil’s eyelashes plays an important role
in traditional medicine. Most parts of this plant
are used in herbal medicine, for which TT can enhance
sex drive and treat urolithiasis, menorrhagia,
impotency, rheumatism pains, and premature
ejaculation (7-9). Khordadmehr and his colleagues
have used TT in an herbal formula, NOFODA, to
investigate its effect on infertile males and concluded
that it improved both sperm motility and
count (10).In studies conducted on animals, TT is thought
to have a luteinizing hormone (LH)-like activity,
which can induce corpus luteum formation in female
rats (11). LH induces the corpus luteum to
secrete progesterone. This results in an increase
in progesterone levels as well as some estrogen
secretion. Studies have shown that protodioscin,
which is found in TT extract, treats mild to moderate
erectile dysfunction and increases libido
(12, 13).In light of the increasing fertility disorders in
opioid users, the present study investigated the effect
of TT on the sex hormones and gonadotropins
of addicted male rats.
Materials and Methods
Experimental animals
Adult male Wister rats that weighed 200 ± 25 g
each (Razi Institute, Iran) were randomly divided
into four groups, of 12 animals each: i. control,
ii. TT-treated, iii. addicted and iv. TT-treated ad-
Ghosian Moghaddam et al.
dicted. The rats were housed in groups of three in
cages at a temperature of 22-25˚C, on a 12 hour
light/12 hour dark schedule and sufficient amounts
of food and water.
Preparation of Tribulus terrestris (TT)
After obtaining TT and verifying its suitability
for our study via the Department of Botany at Shahid
Beheshti University, we ground and combined
the plant with pelleted food at a weight ratio of
6.25%.
Study protocol
Morphine addiction was induced according to
the method of Moini Zanjani et al. (14). Groups
3 and 4 received oral administrations of watersoluble
morphine for 21 days. During this 21-day
period, the treated groups (2 and 4) also received
oral administration of TT plant-mixed pelleted
food (6.25%).The water soluble morphine solution was given
in doses of 0.1, 0.2, and 0.3 mg/ml according to
the method of Swanston-Flatt et al. (15); each of
these doses was administered for 48 hours for the
rats to drink and then 0.4 mg/ml was administered
for the remaining 15 days. The bitterness of morphine
was eliminated by adding 3% sucrose to the
solution. In this experiment, the average amount
of water consumed, and therefore morphine, by
rats was approximately 60-80 mg/ml/day. Addiction
was confirmed by injecting a morphine antagonist
(naloxone) and observing for withdrawal
symptoms.All techniques and methods were approved by
the Ethics Committee of Shahed University of
Medical Sciences. The laboratory animals were afforded
due care in accordance with the regulations
of the Committee for the Purpose of Control and
Supervision on Experiments on Animals (CPCSEA).
Blood sampling
After 21 days of treatment, at treatment termination,
blood samples (3-5cc) were obtained from
all the rats’ hearts to measure hormone levels. The
sera were subsequently separated via centrifuge
(Sigma 4-10, USA) at 2000 rpm for 10 minutes
and stored at -70˚C in a freezer until hormone
analysis.
Plasma analysis
The plasma concentrations of the sex hormones
and gonadotropins were verified by the radioimmunoassay
(RIA) method using kits manufactured
by Monobind Inc. (USA), as well as ELISA kits
(Labsystem, Finland).
Statistical analysis
Obtained data were expressed as mean ± SEM
and statistically analyzed using the one-way analysis
of variance (ANOVA), followed by the posthoc
Tukey test. p<0.05 was considered statistically
significant.
Results
FSH analysis
Our FSH analysis showed that the TT-treated
control group had the least amount of FSH (0.271
± 0.025 mIU/ml), while the morphine-addicted
group had the highest FSH level (0.348 ± 0.022
mIU/ml). Morphine solely did not suppress FSH.
The TT-treated addicted group had a higher FSH
level (0.302 ± 0.01 mIU/ml) than did the TT-treated
control group; there was, however, no significant
change in any of the groups. Figure 1 illustrates
these results.The effect of Tribulus terrestris (TT) on FSH levels
in control and addicted groups. Bars depict mean ± SEM
of LH.
LH analysis
In LH analysis, the addicted group had decreased
LH levels. The highest amount of LH belonged to
the treated control group (0.207 ± 0.098 mIU/ml).
Figure 2 shows a significantly lower LH level in
the addicted group than the control group (0.0125
± 0.017 mIU/ml), which was due to morphine suppression
(p<0.027). The TT-treated addicted group
had a significantly higher amount of LH (0.273 ±
0.066 mIU/ml) than did the control group p<0.031.The effect of Tribulus terrestris (TT) on LH levels
in control and addicted groups. Bars depict mean ± SEM
of LH.* and $; P<0.05 compared between the control and
treated control groups.
Testosterone analysis
In this analysis, there was a reduction in the
addicted group (0.122 ± 0.058 ng/ml). The highest
amount of testosterone belonged to the control
group (0.399 ± 0.04 ng/ml). Figure 3 shows
that the addicted group had the least amount of
testosterone, as a result of morphine suppression.
The treated addicted group had a significantly
lower hormone level (p<0.024) than did
the treated control group (0.193 ± 0.057 ng/ml).
The addicted group had a significantly lower
testosterone level than did the control group
(p<0.001).The effect of Tribulus terrestris (TT) on testosterone
levels in control and addicted groups.Bars depict mean ± SEM of testosterone. *; P<0.05 compared
between the control and treated control groups.
Estrogen analysis
Our estrogen analysis revealed a decrease in
the addicted group compared to the control group
(22.70 ± 3.21 pg/ml). Figure 4 illustrates these results. Compared to the control group, estrogen
decreased in the addicted group; there was a
significant difference between these two groups
(p<0.002). Figure 4 also shows a significant difference
between the treated addicted group and the
treated control group (p<0.048).The effect of Tribulus terrestris (TT) on estrogen levels in
control and addicted groups. Bars depict mean ± SEM of LH.* and $; P<0.05 compared between the control and treated
control groups.
Progesterone analysis
There was an increase in the treated control
group and a decrease in the addicted group
according to progesterone analysis. Figure 5
shows that the treated control group had the
highest hormone level (79.28 ± 5.2 pg/ml),
which was due to TT. The addicted group had
the least amount, which was due to the effects
of morphine. The addicted group had a lower
progesterone level than did the control group;
the difference, however, was not significant. In
comparison with the treated addicted group, the
treated control group had a significant increase
in hormone levels (p<0.002).The effect of Tribulus terrestris (TT) on progesterone
levels in the control and addicted groups. Bars depict mean
± SEM of progesterone.*; P<0.05 compared between the control and treated control
groups.
Discussion
In this study, sex hormone and gonadotropin
levels were evaluated based on the effect of TT
on morphine-addicted rats. FSH, a stimulating
hormone of the ovarian follicles, had a higher
level in our morphine-addicted groups. In the
treated morphine group, the FSH level had the
most decrease, which demonstrated that TT
suppressed FSH release in the addicted rats. A
similar result was observed in the treated control
group; however the difference was not significant.Tabakova and his colleagues, in a comparison
of endocrinal functions before and after
TT therapy, reported that TT acted on the hypothalamus
and reduced FSH levels but did not
decrease ovarian hormones (estrogen and progesterone).
They concluded that TT could be
used to treat menopausal symptoms such as hot
flashes and increase sex drive. These researchers
speculated that the presence of saponin in
TT was responsible for FSH suppression and
the resultant alleviation of hot flashes, irritability,
and depression in menopausal women (16).
However, in our study, no significant effect of
TT on FSH levels was found.We observed a significant decrease in LH levels
in the morphine-addicted group. The treated
addicted group had a relatively higher LH than
did the addicted group, which denoted that TT increased
LH levels. Similarly, the treated control
group had a significantly higher LH level than did
the control group.According to Neychev et al. (17) and a study
by Antonio et al. it was shown that TT induced
LH release. The upswing in LH led to a signal
for testosterone to increase (18). With regard to
testosterone levels, there was a significant decrease
in our addicted rats. In the treated addicted
group, the level was significantly higher
than that of the addicted group. Although TT
affected the increase in testosterone, a number
of studies have demonstrated different results.
Studies demonstrated that TT caused an
increase in testosterone, increase in cavernous
body pressure, increase in systolic pressure, and
increase in penile erection (19-22). In addition,
the effect of TT on castrated rats compared to normal rats was an increase in prostate weight,
which augmented sexual activities and potency
(22). In contrast, Neychev and his colleague reported
that TT did not influence androgen levels
in young men (17). Our results support the
results of a majority of similar studies in the
literature.Based on our study, estrogen decreased significantly
in the addicted group but increased
significantly in the treated addicted group. It
can, therefore, be concluded that TT significantly
increased the estrogen hormone level in
male addicted rats. Of note, there was a dearth
of specific studies on estrogen in the literature.Progesterone decreased in our addicted group;
the amount, however, was insignificant. In contrast,
progesterone significantly increased in
the treated control group. We concluded that TT
increased progesterone in non-addicted cases;
however this increase was not significant in addicted
cases. Mazaro-Costa and colleagues have
reported that not only could TT treat sexual disorders
and dysfunction in menopausal women
but it could also enhance vasomotor actions.
There are, however, no reports on progesterone
specifically (19).
Conclusion
The present study shows that addiction decreases
sex hormones and gonadotropins. Treatment
with TT can increase the hormone levels of testosterone,
progesterone, estrogen, and LH. Nevertheless,
TT did not increase the FSH levels in our
male rats.
Authors: R Abs; J Verhelst; J Maeyaert; J P Van Buyten; F Opsomer; H Adriaensen; J Verlooy; T Van Havenbergh; M Smet; K Van Acker Journal: J Clin Endocrinol Metab Date: 2000-06 Impact factor: 5.958
Authors: Malik Adewoyin; Muhammad Ibrahim; Ramli Roszaman; Muhammad Lokman Md Isa; Nur Aizura Mat Alewi; Ainin Azwani Abdul Rafa; Mohd Nur Nasyriq Anuar Journal: Diseases Date: 2017-03-01
Authors: Kazim Sahin; Mehmet Tuzcu; Cemal Orhan; Hasan Gencoglu; Nurhan Sahin; Fatih Akdemir; Gaffari Turk; Ismet Yilmaz; Vijaya Juturu Journal: Evid Based Complement Alternat Med Date: 2018-04-29 Impact factor: 2.629
Authors: Kazim Sahin; Cemal Orhan; Fatih Akdemir; Mehmet Tuzcu; Hasan Gencoglu; Nurhan Sahin; Gaffari Turk; Ismet Yilmaz; Ibrahim H Ozercan; Vijaya Juturu Journal: BMC Complement Altern Med Date: 2016-08-26 Impact factor: 3.659